Nichi-Iko to sell Lupin's biosimilar drug in Japan Ruby Khatun Khatun20 Jun 2018 10:00 AM ISTNew Delhi: Pharma firms Lupin and Nichi-Iko said that they have entered into a pact for the Japan, promotion, and sale of Lupin's biosimilar drug...
Lavender Investments buys Torrent Pharma stake worth Rs 133 crore Ruby Khatun Khatun20 Jun 2018 9:45 AM ISTNew Delhi: Foreign investor Lavender Investments sold 9 lakh shares of drug firm Torrent Pharmaceuticals for nearly Rs 133 crore through an open...
DreaMed gets FDA approval for diabetes management software Ruby Khatun Khatun20 Jun 2018 9:30 AM ISTTEL AVIV: Israel’s DreaMed Diabetes said the U.S. Food and Drug Administration (FDA) has approved for marketing its Advisor Pro software to help...
Lupin expects single digit sales growth this fiscal Ruby Khatun Khatun19 Jun 2018 10:30 AM ISTNew Delhi: Drug maker Lupin expects single-digit sales growth this fiscal with sluggish US business likely to impact the overall global business of...
Government to study ways for boosting pharma export to China Ruby Khatun Khatun19 Jun 2018 10:15 AM ISTNew Delhi: The commerce ministry has commissioned a study on ways to boost the export of pharmaceutical products to China.The study aims to have a...
FDA declines to approve Valeant's plaque psoriasis lotion Ruby Khatun Khatun19 Jun 2018 9:45 AM ISTValeant Pharmaceuticals International Inc’s plaque psoriasis treatment did not get approval from U.S. health regulators, a setback for the company...
Temporary restraining order for Dr Reddys in US Ruby Khatun Khatun18 Jun 2018 3:04 PM ISTNew Delhi: Indian pharma major Dr Reddy's Laboratories said that a US District Court has issued a temporary restraining order on the sale and...
NCLT allows Fortis to withdraw amalgamation scheme Ruby Khatun Khatun18 Jun 2018 11:05 AM ISTNew Delhi: Fortis Healthcare said National Company Law Tribunal (NCLT) bench in Chandigarh has approved the withdrawal of the scheme of amalgamation...
Sanofi says on track to regain solid position in cancer drugs Ruby Khatun Khatun18 Jun 2018 9:30 AM ISTSanofi believes it can make a comeback and re-establish a leading position in the competitive cancer drug market on the back of its immunotherapy...
Now only online application for New Drugs, FDC and SND: CDSCO tells Pharma Cos Ruby Khatun Khatun17 Jun 2018 10:43 AM ISTNew Delhi: Through a recent notification, Central Drugs Standard Control Organization, Directorate General of Health Services, Ministry of Health and...
Eli Lilly lupus treatment succeeds in mid-stage trial Ruby Khatun Khatun17 Jun 2018 10:41 AM ISTEli Lilly & Co said its drug to treat autoimmune disease lupus met the main goal of a mid-stage trial, positioning the drugmaker to begin a bigger...
USFDA finds deficiencies in Mylan's generic Advair Ruby Khatun Khatun17 Jun 2018 9:41 AM ISTMylan NV said that U.S. health regulators were unable to approve its generic version of GlaxoSmithKline’s blockbuster inhaled lung drug Advair for the...
